These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31004034)

  • 1. Identification of candidate nonsense mutations of FVIII for ribosomal readthrough therapy.
    Liu Z; Zhang Y; Zhu M; Zhang B
    Haematologica; 2019 Dec; 104(12):e573-e576. PubMed ID: 31004034
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations.
    Pinotti M; Caruso P; Canella A; Campioni M; Tagariello G; Castaman G; Giacomelli S; Belvini D; Bernardi F
    Hum Mutat; 2012 Sep; 33(9):1373-6. PubMed ID: 22618954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.
    Branchini A; Ferrarese M; Campioni M; Castaman G; Mari R; Bernardi F; Pinotti M
    Blood; 2017 Apr; 129(16):2303-2307. PubMed ID: 28196793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression.
    Roy B; Friesen WJ; Tomizawa Y; Leszyk JD; Zhuo J; Johnson B; Dakka J; Trotta CR; Xue X; Mutyam V; Keeling KM; Mobley JA; Rowe SM; Bedwell DM; Welch EM; Jacobson A
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12508-12513. PubMed ID: 27702906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.
    Lyu C; Xue F; Liu X; Liu W; Fu R; Sun T; Wu R; Zhang L; Li H; Zhang D; Yang R; Zhang L
    Haemophilia; 2016 Sep; 22(5):e427-34. PubMed ID: 27292088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an in vivo nonsense readthrough assay system and functional analysis of ribosomal proteins S12, S4, and S5 in Bacillus subtilis.
    Inaoka T; Kasai K; Ochi K
    J Bacteriol; 2001 Sep; 183(17):4958-63. PubMed ID: 11489846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational readthrough at
    Testa MF; Lombardi S; Bernardi F; Ferrarese M; Belvini D; Radossi P; Castaman G; Pinotti M; Branchini A
    Haematologica; 2023 Feb; 108(2):472-482. PubMed ID: 35924581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression studies of mutant factor VIII alleles with premature termination codons with regard to inhibitor formation.
    Zimmermann MA; Oldenburg J; Müller CR; Rost S
    Haemophilia; 2014 May; 20(3):e215-21. PubMed ID: 24602271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mutations in exon 14 including five novelties in 13 Italian patients with haemophilia A.
    Acquila M; Pasino M; Lanza T; Molinari AC; Caprino D; Bottini F; Bicocchi MP
    Haemophilia; 2004 Nov; 10(6):744-6. PubMed ID: 15569173
    [No Abstract]   [Full Text] [Related]  

  • 10. Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B.
    Ferrarese M; Testa MF; Balestra D; Bernardi F; Pinotti M; Branchini A
    Hum Mutat; 2018 May; 39(5):702-708. PubMed ID: 29388273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside suppression of nonsense mutations in severe hemophilia.
    James PD; Raut S; Rivard GE; Poon MC; Warner M; McKenna S; Leggo J; Lillicrap D
    Blood; 2005 Nov; 106(9):3043-8. PubMed ID: 16051741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining severity of hemophilia: more than factor levels.
    Pavlova A; Oldenburg J
    Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of recombinant factor replacement for hemophilia.
    Sankar AD; Weyand AC; Pipe SW
    Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilia B is clinically less severe than haemophilia A: further evidence.
    Franchini M; Mannucci PM
    Blood Transfus; 2018 Feb; 16(2):121-122. PubMed ID: 27723453
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum starvation enhances nonsense mutation readthrough.
    Wittenstein A; Caspi M; David Y; Shorer Y; Nadar-Ponniah PT; Rosin-Arbesfeld R
    J Mol Med (Berl); 2019 Dec; 97(12):1695-1710. PubMed ID: 31786671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular genetics of hemophilia A and B in man. Factor VIII and factor IX deficiency.
    Antonarakis SE
    Adv Hum Genet; 1988; 17():27-59. PubMed ID: 3142226
    [No Abstract]   [Full Text] [Related]  

  • 17. A system for coordinated analysis of translational readthrough and nonsense-mediated mRNA decay.
    Baker SL; Hogg JR
    PLoS One; 2017; 12(3):e0173980. PubMed ID: 28323884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification and classification of 41 novel mutations in the factor VIII gene (F8C).
    Cutler JA; Mitchell MJ; Smith MP; Savidge GF
    Hum Mutat; 2002 Mar; 19(3):274-8. PubMed ID: 11857744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside-mediated promotion of translation readthrough occurs through a non-stochastic mechanism that competes with translation termination.
    Chowdhury HM; Siddiqui MA; Kanneganti S; Sharmin N; Chowdhury MW; Nasim MT
    Hum Mol Genet; 2018 Jan; 27(2):373-384. PubMed ID: 29177465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The higher prevalence of missense mutations in hemophilia B compared to hemophilia A could be important in determining a milder clinical phenotype in patients with severe hemophilia B.
    Melchiorre D; Linari S; Castaman G
    Haematologica; 2016 Oct; 101(10):e429. PubMed ID: 27694504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.